The goal of this research application is to define cellular interactions that guide T lymphocyte development. Experiments performed in the previous funding period have focused on recognition events involved in positive selection, and have established that, 1) positive selection occurs on conventional peptide/MHC complexes, that 2) peptides presented in the thymus are involved in shaping the T cell repertoire, and yet that 3) recognition of positive selection is promiscuous. In the current application, it is argued that recognition events of positive selection can only be understood if the natural ligands of positive selection are known. Yet, for conventional T cell receptor transgenic mice, it will be impossible to identify a single or few naturally-occurring positively selecting peptide(s), partly because positive selection is promiscuous in nature, and it is possible that positive selection occurs on a """"""""gemisch"""""""" of different peptides. Therefore, an experimental model will be specifically designed to limit the number of candidate positively-selecting peptides. The studies in this application are directed toward generating a novel T cell receptor transgenic mouse in which the number of positively selecting peptides is limited to thirteen peptides, of defined sequence. Identification of the natural ligand(s) of positive selection in this system will make it possible to test the validity of the current hypothesis of positive selection. The final goal of the application is the definitive characterization of recognition events of positive selection.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD026841-10
Application #
6151141
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Hewitt, Tyl
Project Start
1991-02-01
Project End
2003-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
10
Fiscal Year
2000
Total Cost
$279,533
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Irion, S; Berg, R E; Staerz, U D (2000) A physiological ligand of positive selection is seen with high specificity. J Immunol 164:4601-6
Staerz, U D; Lee, D S; Qi, Y (2000) Induction of specific immune tolerance with hybrid antibodies. Immunol Today 21:172-6
Berg, R E; Irion, S; Kattman, S et al. (2000) A physiological ligand of positive selection is recognized as a weak agonist. J Immunol 165:4209-16
Berg, R E; Princiotta, M F; Irion, S et al. (1999) Positive selection of an H2-M3 restricted T cell receptor. Immunity 11:33-43
Staerz, U D; Qi, Y (1999) Treatment of an autoimmune disease with ""classical"" T cell veto: a proposal. J Clin Immunol 19:195-202
Qi, Y; Staerz, U D (1998) Specific inhibition of CD4+ T lymphocytes by a hybrid antibody. Nat Biotechnol 16:271-5
Princiotta, M F; Lenz, L L; Bevan, M J et al. (1998) H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med 187:1711-9
Qi, Y; Berg, R; Singleton, M A et al. (1996) Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med 183:1973-80
Candeias, S; Hardy, R R; Li, Y S et al. (1994) T cell receptor V beta 8.2 gene germ-line transcription: an early event of lymphocyte differentiation. Eur J Immunol 24:3073-81